Bristol-Myers Squibb Co

Common Name
Bristol-Myers Squibb
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
34,100
Ticker
BMY
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Bristol-Myers Squibb Company is a renowned pharmaceutical corporation engaged in the discovery, development, and distribution of innovative medicines. The company's core focus lies in providing therap...

Bristol-Myers Squibb Waste Data Preview

In 2023, Bristol-Myers Squibb conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Bristol-Myers Squibb's Waste Treatment Practices

In 2023, Bristol-Myers Squibb generated a total of 11,479 metric tonnes of waste.

Of this amount, 51.62% of Bristol-Myers Squibb's total waste generated was recovered through methods such as recycling, reuse, or composting, while 48.38% was disposed of through landfilling, incineration, or combustion.

Bristol-Myers Squibb's Waste Recovery Rate

52%

How much of Bristol-Myers Squibb's waste is recycled or recovered?

In 2023, Bristol-Myers Squibb reported a total waste generation of 11,479 metric tonnes, of which 51.62% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Bristol-Myers Squibb is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.

Has Bristol-Myers Squibb reduced its environmental waste footprint over time?

Since 2023, Bristol-Myers Squibb's total waste generation has decreased by 14.69%, suggesting improvements in operational efficiency or the early results of waste minimization strategies.

Over the same period, Bristol-Myers Squibb's waste recovery rate increased by 12.29%.

Bristol-Myers Squibb’s Waste Recovery vs. Disposal Over Time

2022202303.5 k7 k10.5 k14 ktonnes
  • Total Waste Disposed
  • Total Waste Recovered

Insights into Bristol-Myers Squibb’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Bristol-Myers Squibb generated a total of 11,479 metric tonnes of waste.

Of this amount, 15.48% of Bristol-Myers Squibb's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 32.9% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls. The remaining 51.62% was either treated using unspecified methods or not clearly categorized.

Bristol-Myers Squibb’s Hazardous vs Non-Hazardous Waste Over Time

2022202302 k4 k6 k8 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Bristol-Myers Squibb reduced the environmental impact of its waste?

Since 2023, Bristol-Myers Squibb's total waste generation has decreased by 14.69%, suggesting improvements in operational efficiency or the early results of waste minimization strategies.

Overall, Bristol-Myers Squibb's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.

Want Full Access to Bristol-Myers Squibb's Waste Management Dataset?
Sign Up